Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you missed your Mounjaro dose by two days, inject it as soon as you remember — provided your next scheduled dose is still at least four days away. That four-day gap is the deciding rule. Miss it, and you skip the forgotten dose entirely and carry on from your usual day. Mounjaro is a prescription-only medicine, so any lasting uncertainty about your schedule is best resolved with your prescriber rather than a forum. The guidance below explains the reasoning behind that rule and what it means in practice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide, the active ingredient in Mounjaro, has a long half-life of around five days. That means even two days after a missed injection the medicine is still circulating and working, it hasn't simply switched off. The four-day threshold exists because it preserves a safe, predictable gap between doses. Getting two injections too close together doesn't give you a boost; it gives you a higher chance of feeling sick, experiencing stomach cramps, or dealing with the kind of nausea that puts people off continuing treatment.
The NHS tirzepatide patient guide is explicit on this point: inject as soon as you remember if it is more than four days before your next scheduled dose, and change your injection day to that new date going forward if that's easier. If fewer than four days remain, leave the missed dose and inject on your normal day as planned. The key thing is that your weekly rhythm (not a double dose) is what keeps side effects manageable and results consistent.
Think of it this way: tirzepatide's design is a slow, sustained signal to the body. Disrupting that with a compressed schedule sends the wrong kind of signal.
In most cases, not much that is immediately noticeable. Two days is well within the window where the medicine is still active. You may notice appetite returning slightly in the days before you remember, which is normal, appetite suppression does ease as the week progresses even on a perfect schedule. What a two-day delay does not do is reset your dose level, undo your progress, or require you to restart titration from 2.5mg.
If a two-day delay becomes a pattern, that is worth a conversation with your prescriber. Irregular dosing can make it harder to distinguish genuine side effects from timing-related fluctuations, and your prescriber may have practical suggestions, a recurring phone reminder, a different day of the week, or simply a note in the fridge. Speaking of which: the pen itself lives in the fridge, so tying your injection day to something that already happens in the kitchen each week is one of the simplest fixes people find.
For broader context on how the injection schedule fits into treatment, the Mounjaro overview page covers how titration works and what to expect across the dose steps.
If you injected two days late and it worked out fine, you have a choice: keep your original day (which means your next dose comes slightly sooner than seven days after the late injection), or shift your weekly day to match the new date. Both are acceptable, provided consecutive injections are always at least four days apart. Most people find it simpler to move the day permanently so the schedule feels natural again, but this is a personal preference rather than a clinical requirement.
What you should not do is try to recalibrate by splitting or adjusting the dose in the pen itself, and if you want to understand how breaking the Mounjaro pen works for a golden dose, that guidance explains why the pen is calibrated for one use at the prescribed strength. If you have questions about specific dose levels (for instance, what to expect at 5mg) those are worth discussing with your prescriber before you titrate, not in the middle of catching up on a missed week.
A more sustained gap (missing a full week rather than two days) changes the calculation. If that has happened, the guidance on missing a week of Mounjaro covers what to consider, including whether dose-stepping back might be appropriate.
A single two-day delay does not usually need clinical input, and our full guidance on missed dosage of Mounjaro walks through what to do across the range of timing scenarios. But there are situations where it is worth reaching out. These include: repeated missed doses over several weeks; a missed dose that coincides with a new symptom you are unsure about; or uncertainty about your schedule because you are also managing other medicines that interact with timing.
The MHRA's Yellow Card scheme is the right channel if you experience an unexpected side effect after a late or doubled dose, reporting helps regulators track patterns across the population.
If you are on treatment through nume, our prescribers are available for aftercare seven days a week. There is no need to wait for a scheduled review if something feels off. For anyone who has not yet started treatment and wants a clinical assessment from a GPhC-registered prescriber, the process is straightforward, checking your eligibility is the first step and costs nothing.
For a fuller look at the general principles covering all timing scenarios, the general missed Mounjaro dose guidance is a useful reference alongside this page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.